Bosello, Silvia Laura
 Distribuzione geografica
Continente #
EU - Europa 3.414
NA - Nord America 3.139
AS - Asia 1.709
SA - Sud America 356
AF - Africa 35
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 8.677
Nazione #
US - Stati Uniti d'America 3.101
DE - Germania 1.040
CN - Cina 641
IT - Italia 593
SG - Singapore 577
SE - Svezia 509
BR - Brasile 328
FR - Francia 315
UA - Ucraina 230
IE - Irlanda 182
GB - Regno Unito 137
ID - Indonesia 127
IN - India 127
FI - Finlandia 93
RU - Federazione Russa 83
PL - Polonia 79
KR - Corea 56
TR - Turchia 51
BE - Belgio 42
CA - Canada 28
HK - Hong Kong 28
IR - Iran 20
NL - Olanda 19
AT - Austria 18
AU - Australia 14
JP - Giappone 13
CI - Costa d'Avorio 12
PK - Pakistan 11
AR - Argentina 10
CZ - Repubblica Ceca 10
ES - Italia 10
LT - Lituania 9
RO - Romania 8
IQ - Iraq 7
PT - Portogallo 7
ZA - Sudafrica 7
EU - Europa 6
MA - Marocco 6
BD - Bangladesh 5
CO - Colombia 5
DK - Danimarca 5
EC - Ecuador 5
MX - Messico 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
HU - Ungheria 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CH - Svizzera 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
SA - Arabia Saudita 3
VE - Venezuela 3
VN - Vietnam 3
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PH - Filippine 2
SI - Slovenia 2
TJ - Tagikistan 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
TH - Thailandia 1
UG - Uganda 1
Totale 8.677
Città #
Chandler 590
Singapore 395
Ashburn 238
Dublin 181
Ann Arbor 173
Jacksonville 132
Jakarta 126
Dearborn 121
Rome 108
San Mateo 96
New York 90
Milan 88
Wilmington 88
Woodbridge 84
Nanjing 82
Houston 72
Seattle 71
Kraków 64
Hefei 62
Fairfield 61
Moscow 56
Munich 56
Seoul 56
Boston 48
Nürnberg 48
Frankfurt am Main 44
Marseille 43
Beijing 42
Lawrence 42
Brussels 41
Helsinki 41
Los Angeles 41
Izmir 39
The Dalles 38
Cattolica 37
Bremen 35
Nanchang 34
Pune 32
Düsseldorf 28
Nuremberg 28
Redwood City 28
Princeton 25
Guangzhou 24
Chicago 23
Hebei 23
Hong Kong 23
Norwalk 23
Kunming 21
Paris 20
São Paulo 20
Boardman 18
London 18
Hyderabad 17
Lancaster 17
Tianjin 17
Augusta 16
Leawood 16
Trieste 16
Cambridge 15
Falls Church 15
Fremont 15
Belo Horizonte 14
Andover 13
North Bergen 13
Abidjan 12
Detroit 12
Shanghai 12
Toronto 12
Mountain View 11
Redmond 11
University Park 11
Hangzhou 10
Jiaxing 10
Lauterbourg 10
Shenyang 10
Bexley 9
Palermo 9
Santa Clara 9
Washington 9
Zhengzhou 9
Atlanta 8
Changsha 8
Falkenstein 8
Florence 8
Kish 8
Phoenix 8
San Francisco 8
Warsaw 8
Ottawa 7
Porto Alegre 7
Tokyo 7
Campinas 6
Dallas 6
Monmouth Junction 6
Portsmouth 6
Rio de Janeiro 6
Vienna 6
Ardabil 5
Brno 5
Busto Arsizio 5
Totale 4.503
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 330
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 251
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 204
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 198
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 182
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 177
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 173
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 152
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 146
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 145
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 144
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 139
Assessment of neurological manifestations in hospitalized patients with COVID-19 137
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 134
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 133
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 131
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 128
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 124
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 124
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 122
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 120
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 120
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 120
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 119
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 118
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 109
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 107
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 102
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 97
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 97
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 96
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 96
Sarilumab use in severe SARS-CoV-2 pneumonia 96
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 95
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 92
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 89
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 86
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 86
Adult-onset Still's disease following COVID-19 vaccination 86
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 84
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 81
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 80
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 77
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 77
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 76
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 76
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 76
Troponin in Stable Ischemic Heart Disease and Diabetes 72
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 72
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 72
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 70
An unusual lung involvement in scleroderma: lipoid pneumonia 69
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 68
Troponin in Stable Ischemic Heart Disease and Diabetes 66
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 66
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 65
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 64
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 58
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 55
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 54
Arthritis in systemic vasculitis: a retrospective analysis 53
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 53
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 53
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 52
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 52
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 52
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 51
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 50
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 49
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 49
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 47
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 47
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 46
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 44
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 42
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 42
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 40
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 39
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 37
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 37
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 37
A Comprehensive Natural Language Processing Pipeline for the Chronic Lupus Disease 36
Reply to: Individuality of the composition of the human microbiota 36
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 34
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 34
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 34
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 33
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 32
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 32
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 31
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 31
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 30
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 30
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 30
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 30
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 29
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 29
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 29
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 29
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 28
Totale 8.252
Categoria #
all - tutte 43.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 0 0 0 0 51
2020/2021747 29 54 197 49 87 21 51 20 87 28 107 17
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.698 214 235 128 273 84 191 85 140 153 16 58 121
2023/20241.095 37 280 54 59 38 150 76 79 23 35 154 110
2024/20252.277 49 51 219 86 256 115 114 115 362 276 559 75
Totale 8.858